AnalystsMartin FanMartin Fan's Stock Forecasts
AnalystsMartin Fan
Sectors:
Industries:
Analyst Ranking
Top 12%
#612 out of 5290 analysts
Average Return
+42.02%
Win Rate
54%15 out of 28
Risk vs Reward
Poor
Good
Martin Fan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Oruka Therapeutics IncORKA | +575.48% | $9.46 | $63.90 | 2025-05-14 - 2026-05-14 | Buy |
Aclaris Therapeutics IncACRS | +224.82% | $1.41 | $4.58 | 2025-05-27 - 2026-05-27 | Buy |
Anaptysbio IncANAB | +202.90% | $21.70 | $65.73 | 2025-04-30 - 2026-04-30 | Buy |
Anaptysbio IncANAB | +151.55% | $20.37 | $51.24 | 2025-08-06 - 2026-06-03 | Buy |
Oruka Therapeutics IncORKA | +82.51% | $31.34 | $57.20 | 2026-01-12 - 2026-06-03 | Buy |
Martin Fan Analyst Color
Get additional color on Martin Fan's coverage of popular stocks
Martin Fan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cartesian Therapeutics IncRNAC | 4 | Buy | $38.00 | +506.54% | Reiterates | 9 days ago |
Vor Biopharma IncVOR | 3 | Hold | $18.00 | +33.93% | Maintains | 22 days ago |
Imagenebio IncIMA | 2 | Sell | $2.00 | -63.30% | Reiterates | 25 days ago |
Nektar TherapeuticsNKTR | 3 | Hold | $80.00 | +35.07% | Maintains | 25 days ago |
Artiva Biotherapeutics IncARTV | 3 | Buy | $40.00 | +473.89% | Maintains | 25 days ago |
Aclaris Therapeutics IncACRS | 3 | Buy | $10.00 | +126.24% | Maintains | a month ago |
Oruka Therapeutics IncORKA | 4 | Buy | $85.00 | +48.60% | Maintains | 2 months ago |
Sana Biotechnology IncSANA | 3 | Buy | $7.00 | +124.36% | Maintains | 2 months ago |
Anaptysbio IncANAB | 6 | Buy | $75.00 | +46.37% | Maintains | 3 months ago |
Zura Bio LtdZURA | 1 | Buy | $15.00 | +288.60% | Initiates Coverage On | 4 months ago |
Zenas Biopharma IncZBIO | 2 | Buy | $45.00 | +158.62% | Reiterates | 5 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.